Alkermes Plc  

(Public, NASDAQ:ALKS)   Watch this stock  
Find more results for JAMES BLOOM
42.97
+0.21 (0.49%)
Aug 1 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 42.39 - 43.83
52 week 29.36 - 54.25
Open 42.53
Vol / Avg. 1.26M/795,144.00
Mkt cap 6.21B
P/E     -
Div/yield     -
EPS -0.05
Shares 144.52M
Beta 0.97
Inst. own 96%
Jul 31, 2014
Q2 2014 Alkermes plc Earnings Release
Jul 31, 2014
Q2 2014 Alkermes Plc Earnings Call - Webcast
Jun 10, 2014
Alkermes plc at Goldman Sachs Healthcare Conference
Jun 2, 2014
Alkermes plc at Jefferies Global Healthcare Conference - Webcast
May 28, 2014
Alkermes plc Annual Shareholder Meeting
May 19, 2014
Alkermes plc at UBS Global Healthcare Conference - Webcast
May 6, 2014
Alkermes plc at Mizuho Securities USA Healthcare Corporate Access Day
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -18.70% -
Operating margin -12.21% -
EBITD margin - -
Return on average assets -5.72% -
Return on average equity -8.12% -
Employees 1,250 -
CDP Score - -

Address

Connaught House 1 Burlington Road, Dublin 4
DUBLIN,
Ireland
+353-1-7728000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alkermes Public Limited Company is an integrated, global biopharmaceutical company. The Company has a portfolio of more than 20 commercial drug products and a clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. The Company manufactures RISPERDAL CONSTA, VIVITROL and polymer for BYDUREON in its Wilmington, Ohio facility. The Company operates PERDAL CONSTA lines and one VIVITROL line at commercial scale. The Company manufactures AMPYRA/FAMPYRA, RAPAMUNE and other products in its Athlone, Ireland facility. It manufactures FOCALIN XR, RITALIN LA, AVINZA, VERAPAMIL and other products in its Gainesville, Georgia facility.

Officers and directors

Richard F. Pops Chairman, President, and CEO
James M. (Jim) Frates SVP, CFO, and Treasurer
Gordon G. Pugh SVP, COO, and Chief Risk Officer
Richard F. Pops Chairman of the Board, Chief Executive Officer
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Shane Cooke President
Age: 51
Bio & Compensation  - Reuters
James M. Frates Chief Financial Officer, Senior Vice President
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Gordon G. Pugh Chief Operating Officer, Senior Vice President, Chief Risk Officer
Age: 55
Bio & Compensation  - Reuters
Kathryn L. Biberstein Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Rebecca J. Peterson Senior Vice President
Age: 38
Bio & Compensation  - Reuters
James L. Botkin Senior Vice President - Operations
Age: 64
Bio & Compensation  - Reuters